July 10, 2014 11:51 PM ET

Biotechnology

Company Overview of Koronis Pharma, Inc.

Executive Profile

John M. Essigmann Ph.D.

Scientific Advisor, Koronis Pharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

Dr. John M. Essigmann, Ph.D. serves as a Scientific Advisor at Koronis Pharmaceuticals, Inc. Dr. Essigmann is Professor of Toxicology and Chemistry at MIT. He has served as chairman of the Gordon Conference on Mutagenesis. He received his Ph.D. and did his postdoctoral research at the Massachusetts Institute of Technology.

Corporate Headquarters

500 Union Street
Seattle, Washington 98101

United States

Phone: 206-682-1181
Fax: 206-682-8077

Board Members Memberships

There is no Board Members Memberships data available.

Education

PhD
Massachusetts Institute of Technology
Post-Doctoral Training
Massachusetts Institute of Technology

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Koronis Pharma, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.